Colony Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$3.69M Sell
51,833
-2,696
-5% -$202K 0.06% 249
2023
Q2
$4.2M Buy
54,529
+5,815
+12% +$450K 0.06% 245
2023
Q1
$3.66M Sell
48,714
-15,557
-24% -$1.16M 0.05% 265
2022
Q4
$5.06M Buy
64,271
+12,036
+23% +$902K 0.07% 228
2022
Q3
$3.67M Buy
52,235
+4,248
+9% +$333K 0.06% 249
2022
Q2
$3.85M Buy
47,987
+538
+1% +$42.1K 0.07% 235
2022
Q1
$3.6M Buy
47,449
+4,573
+11% +$362K 0.05% 275
2021
Q4
$3.66M Sell
42,876
-1,658
-4% -$129K 0.06% 245
2021
Q3
$3.37M Sell
44,534
-371
-0.8% -$29.5K 0.06% 236
2021
Q2
$3.65M Sell
44,905
-3,574
-7% -$292K 0.07% 211
2021
Q1
$3.82M Sell
48,479
-2,478
-5% -$194K 0.08% 210
2020
Q4
$4.36M Sell
50,957
-599
-1% -$49.5K 0.1% 176
2020
Q3
$3.98M Buy
51,556
+2,215
+4% +$169K 0.1% 176
2020
Q2
$3.62M Sell
49,341
-3,692
-7% -$262K 0.1% 177
2020
Q1
$3.52M Sell
53,033
-66
-0.1% -$4.66K 0.11% 174
2019
Q4
$3.65M Buy
53,099
+17,909
+51% +$1.22M 0.09% 205
2019
Q3
$2.59M Buy
35,190
+27
+0.1% +$1.96K 0.08% 230
2019
Q2
$2.52M Buy
35,163
+6,373
+22% +$452K 0.08% 232
2019
Q1
$1.97M Buy
28,790
+2,935
+11% +$190K 0.08% 200
2018
Q4
$1.54M Sell
25,855
-619
-2% -$38.7K 0.07% 223
2018
Q3
$1.77M Buy
26,474
+238
+0.9% +$15.9K 0.09% 212
2018
Q2
$1.7M Sell
26,236
-2,412
-8% -$158K 0.09% 214
2018
Q1
$2.05M Buy
28,648
+2,188
+8% +$157K 0.11% 185
2017
Q4
$2M Buy
26,460
+7,326
+38% +$535K 0.13% 174
2017
Q3
$1.39M Buy
19,134
+1,715
+10% +$124K 0.1% 205
2017
Q2
$1.29M Buy
17,419
+1,219
+8% +$90.5K 0.09% 209
2017
Q1
$1.19M Sell
16,200
-850
-5% -$59.5K 0.11% 165
2016
Q4
$1.12M Hold
17,050
0.12% 163
2016
Q3
$1.26M Sell
17,050
-300
-2% -$22.2K 0.14% 140
2016
Q2
$1.27M Sell
17,350
-4
-0% -$285 0.14% 133
2016
Q1
$1.23M Buy
17,354
+604
+4% +$40.2K 0.14% 130
2015
Q4
$1.12M Sell
16,750
-300
-2% -$20K 0.1% 179
2015
Q3
$1.08M Buy
17,050
+300
+2% +$19.6K 0.13% 155
2015
Q2
$1.1M Buy
16,750
+3,400
+25% +$231K 0.12% 167
2015
Q1
$926K Sell
13,350
-152
-1% -$10.5K 0.1% 168
2014
Q4
$934K Sell
13,502
-1,463
-10% -$98.8K 0.1% 189
2014
Q3
$976K Buy
14,965
+63
+0.4% +$4.16K 0.11% 163
2014
Q2
$1.02M Sell
14,902
-160
-1% -$10.7K 0.14% 118
2014
Q1
$977K Sell
15,062
-3,100
-17% -$195K 0.13% 121
2013
Q4
$1.18M Buy
+18,162
New +$1.16M 0.17% 111
2013
Q3
Sell
-10,413
Closed -$596K 160
2013
Q2
$596K Buy
+10,413
New +$618K 0.12% 97

Other funds holding CL

Colony Group's CL Position: Q3 2023 in Review

Colony Group reduced its Colgate-Palmolive (CL) stake by 4.9% in Q3 2023, selling an estimated $202K and leaving 51,833 shares worth $3.69M. The position accounts for 0.06% of the portfolio, ranked #249.

Colony Group first reported a position in CL in Q2 2013 and has held it in 41 quarters since. The position peaked at $5.06M in Q4 2022. 1,621 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Colony Group held 51,833 shares of Colgate-Palmolive worth $3.69M as of Q3 2023.
  • Colony Group sold 2,696 Colgate-Palmolive shares in Q3 2023, an estimated $202K.
  • Colgate-Palmolive made up 0.06% of Colony Group's portfolio in Q3 2023, its #249 holding.
  • Colony Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 41 quarters since.
  • Colony Group's Colgate-Palmolive position peaked at $5.06M in Q4 2022.
  • 1,621 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.